SEC Filing Analysis: MAIA Biotechnology, Inc. (MAIA)

Executive Summary

• Trading Significance: Medium
• Key Takeaway: Director Ramiro Guerrero purchased 133,790 shares of common stock for $184,103 in direct open market transactions.
• Market Impact: Neutral to slightly positive due to open-market direct insider accumulation representing 0.22% of shares outstanding.

Company Information

Field	Value
Company	MAIA Biotechnology, Inc.
Ticker Symbol	MAIA
CIK	0001878313
Industry	Pharmaceutical Preparations

Insider Information

Field	Value
Name	Guerrero Ramiro
CIK	0001913253
Title/Position	Director
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-08-26 to 2026-08-28
Transaction Code	P (Purchase)
Security Type	Common Stock
Shares Involved	133,790
Price Per Share	$1.35 - $1.39 (Avg ~$1.38)
Total Value	$184,103.30
Shares Owned After	735,701
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$184,103.30
% of Market Cap	0.23%
Shares Transacted	133,790
% of Shares Outstanding	0.22%
Post-Transaction Ownership	735,701 shares (1.21% of outstanding)
Materiality Assessment	Moderate

Impact Evaluation

• Market Cap Context: Across a micro-cap valuation of $80M, an open-market purchase of ~$184K represents a solid insider commitment.
• Ownership Concentration: Insider ownership grew from 601,911 to 735,701 shares, increasing the director's stake by 22.23%.
• Dilution Impact: None; open-market purchase of existing common shares.
• Transaction Significance: The purchase represents 0.23% of market capitalization, reflecting meaningful alignment with public shareholders.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: While open-market direct buying is a constructive signal, the transaction volume is moderate and unlikely to move broader market prices significantly on its own.

Volume & Sentiment

• Expected Volume Impact: Low to moderate relative to regular trading volume.
• Sentiment Indicator: Bullish (Insider accumulation).

Additional Context

Transaction Notes

• Timing: Executed across three trading days (August 26-28, 2026).
• Special Circumstances: The filing indicates aff10b5One is 0, confirming these transactions were discretionary open-market buys rather than pre-scheduled plan executions.